Nkarta Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$2.30

-0.09 (-3.77%)

As of Aug 13, 10:09 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 11 92%

Hold 1 8%

Sell 0 0%

Price Target

Analyst Price Target +620.4% upside

Low Target $14.06

Average Target $16.57

High Target $23.26

Current Price $2.30

Current
$2.30

Target
$16.57

$14.06 $16.57 avg $23.26

Scenario Analysis

Bear Case

$14.06

511.3%

Low target

Base Case

$16.57

+620.4%

Avg target

Bull Case

$23.26

+911.3%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$3.72

-38.2% from high

52-Week Low

$1.70

+35.3% from low

Target vs 52W High

$16.57

+345.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+3.3%
AMGN Amgen Inc	Hold	43	49%	$190.87	-54.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-13.3%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.4%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-53.9%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.0%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.4%